Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606295 | PMC |
| http://dx.doi.org/10.1016/j.jdcr.2021.10.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.
Dermatitis
November 2024
Galaria Plastic Surgery & Dermatology, LLC, Chantilly, Virginia, USA.
Article Synopsis
- The review examines the dermatologic side effects of psychedelic and hallucinogenic substances, which are not well understood despite their therapeutic use.
- A comprehensive search of medical databases identified 22 studies linking these drugs to various skin reactions in 40 patients.
- Common skin reactions included hypersensitivity to cannabis, acneiform and urticarial eruptions from MDMA, and various reactions from ketamine and psilocybin, with most cases resolving after stopping the drug.
Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
Int J Dermatol
January 2024
Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Article Synopsis
- Cutaneous manifestations of COVID-19 in African populations are under-researched and might help in early diagnosis and prognosis of the disease.
- A literature review from December 2019 to March 2023 highlighted various skin lesions like multisystem inflammatory syndrome (MIS), showing differences based on severity and country.
- The study found that certain health conditions (like obesity and diabetes) are associated with these skin manifestations, which can emerge early, potentially aiding in the identification of COVID-19 cases.
Dermatological manifestations of the Coronavirus disease 2019 in children: a systemic review.
Postepy Dermatol Alergol
June 2022
Dermatology Department, Centre of Postgraduate Medical Education/Central Clinical Hospital MSWiA, Warsaw, Poland.
Introduction: An increasing number of publications describing dermatoses associated with Coronavirus disease 2019 (COVID-19) have shown differences in the morphology and incidence of dermatoses in children compared to the general population.
Material And Methods: Among 22 selected full-text articles, dermatoses associated with COVID-19 have been described in 196 children (average age: 12.57 years).
Urticaria multiforme-like eruption due to a novel agent elexacaftor/tezacaftor/ivacaftor in a pediatric patient with cystic fibrosis.
JAAD Case Rep
December 2021
Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan.
Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients.
Dermatol Ther
February 2022
Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Considering the emergency approval of the Food and Drug Administration for widespread use of coronavirus disease 2019 (COVID-19) vaccines, evaluating potential vaccine-related adverse effects is critical as it will allow physicians to diagnose and manage these complications properly. In this descriptive cross-sectional questionnaire-based study, we evaluated the possible side effects of the COVID-19 vaccine from June 1, 2021 to June 21, 2021. The Iranian population is generally vaccinated with AstraZeneca, Sputnik V, Sinopharm, and Bharat vaccines.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!